AMKR vs DT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMKR demonstrates strong financial health with a Piotroski F-Score of 8/9, indicating robust operational efficiency and profitability trends. The company trades at a forward P/E of 18.15, below the sector average of 77.27, suggesting relative undervaluation despite high growth expectations. Earnings growth of 61% YoY and consistent earnings beats (3/4 in last 4 quarters) reinforce its momentum. However, the absence of an Altman Z-Score and bearish insider activity (4 sales totaling $2.83M) introduce cautionary signals. The intrinsic value of $44.25 exceeds the current price of $41.61, supporting a fair value upside.
Dynatrace exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and a pristine balance sheet (Debt/Equity 0.03). However, there is a severe valuation disconnect, as the current price of $35.29 trades significantly above the Graham Number ($11.13) and Intrinsic Value ($4.20). While the company maintains elite gross margins (81.75%) and a consistent track record of earnings beats, the massive YoY earnings decline (-89.10%) and bearish technical trend (0/100) offset the bullish analyst consensus.
Compare Another Pair
Related Comparisons
AMKR vs DT: Head-to-Head Comparison
This page compares Amkor Technology, Inc. (AMKR) and Dynatrace, Inc. (DT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.